PME.AX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 09:10):

Stats
Šios dienos apimtis	201 691
Vidutinė apimtis	335 849
Rinkos kapitalizacija	11.42B
EPS	$0 ( 2024-02-14 )
Last Dividend	$0.170 ( 2023-09-06 )
Next Dividend	$0 ( N/A )
P/E	163.25
ATR14	$0.0930 (0.08%)

Tūris Koreliacija

Ilgas: 0.06 (neutral)

Trumpas: -0.79 (moderate negative)

Signal:(50.322) Neutral

Pro Medicus Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Pro Medicus Ltd Koreliacija - Valiuta/Žaliavos

-0.03
( neutral )

0.10
( neutral )

0.00
( neutral )

-0.24
( neutral )

0.34
( neutral )

0.03
( neutral )

Pro Medicus Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	$124.90M
Bruto pelnas:	$92.37M (73.95 %)
EPS:	$0.580

FY	2023
Pajamos:	$124.90M
Bruto pelnas:	$92.37M (73.95 %)
EPS:	$0.580

FY	2022
Pajamos:	$93.46M
Bruto pelnas:	$70.28M (75.20 %)
EPS:	$0.430

FY	2021
Pajamos:	$67.84M
Bruto pelnas:	$67.35M (99.28 %)
EPS:	$0.297

Financial Reports:

No articles found.

Pro Medicus Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0 (N/A)	$0.130 (N/A)	$0 (N/A)	$0.170 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Pro Medicus Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.13 - Increase likely (42.52%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0100	2001-03-16
Last Dividend	$0.170	2023-09-06
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	45	--
Total Paid Out	$1.503	--
Avg. Dividend % Per Year	0.00%	--
Score	4.27	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.13
Div. Directional Score	9.40	--

Next Divdend (Est)
(2024-07-17)

$0.180 Estimate 7.42 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.27

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SUN.AX	Ex Dividend Junior	2023-08-14	Semi-Annually	0.00%
CQE.AX	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
NAC.AX	Ex Dividend Knight	2023-09-06	Quarterly	0.00%
WHF.AX	Ex Dividend Knight	2023-05-29	Semi-Annually	0.00%
EVN.AX	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
PGF.AX	Ex Dividend Junior	2023-09-13	Semi-Annually	0.00%
ANN.AX	Ex Dividend Knight	2023-08-18	Semi-Annually	0.00%
HPI.AX	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
RIO.AX	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
BTI.AX	Ex Dividend Junior	2023-08-21	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.490	1.500	0.190	0.285	[0 - 0.5]
returnOnAssetsTTM	0.326	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.468	1.500	5.91	8.87	[0.1 - 1]
payoutRatioTTM	0.449	-1.000	5.51	-5.51	[0 - 1]
currentRatioTTM	7.49	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.45	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	4.25	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00721	-1.500	9.88	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.658	2.00	9.67	10.00	[0 - 20]
debtEquityRatioTTM	0.00970	-1.500	9.96	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.741	1.000	0.982	0.982	[0.2 - 0.8]
operatingProfitMarginTTM	0.673	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	48.73	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.664	0.800	8.91	7.13	[0.5 - 2]
Total Score				11.67

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	163.86	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.468	2.50	7.37	8.87	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.658	2.00	9.78	10.00	[0 - 30]
dividendYielPercentageTTM	0.320	1.500	2.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
payoutRatioTTM	0.449	1.500	5.51	-5.51	[0 - 1]
pegRatioTTM	3.78	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.530	1.000	10.00	0	[0.1 - 0.5]
Total Score				7.13

Pro Medicus Ltd

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.